TONYA PUSKI: Open Payments
NPI 1518021955 · JOHNSTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 18 payments from 9 companies in 2025. Trend: 2023 $122 · 2024 $0 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $16 |
Products named: REXULTI, CAPLYTA, ABILIFY MAINTENA, COBENFY, Auvelity, SPRAVATO, FANAPT, INGREZZA.
Industry payments across IA — which companies pay providers there.
